Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.

Abstract : Hormone therapy (HT) increases venous thromboembolism (VTE) risk among postmenopausal women. Data on the influence of steroids receptors polymorphisms on this association remain scarce. Since progesterone receptor (hPR) is expressed in human veins and specific progestogens increase VTE risk, we investigated the impact of the functional +331G/A hPR polymorphism on the association of VTE with HT. Using the data of the ESTHER study, we showed that ORs for VTE in current users of progesterone or progestins were not significantly different by hPR+331G/A genotype status. hPR polymorphism appears not to have a significant effect on VTE risk related to HT.
Type de document :
Article dans une revue
Maturitas, Elsevier, 2009, 64 (2), pp.136-8. 〈10.1016/j.maturitas.2009.08.013〉
Liste complète des métadonnées

Littérature citée [8 références]  Voir  Masquer  Télécharger

http://www.hal.inserm.fr/inserm-01142841
Contributeur : Pascale Sztajnbok <>
Soumis le : jeudi 16 avril 2015 - 10:03:47
Dernière modification le : mercredi 29 novembre 2017 - 09:31:52
Document(s) archivé(s) le : lundi 14 septembre 2015 - 09:36:22

Fichier

Bouaziz_Maturitas_2009.pdf
Fichiers produits par l'(les) auteur(s)

Identifiants

Collections

Citation

Elodie Bouaziz, Marianne Canonico, Céline Verstuyft, Laure Carcaillon, Frédéric Martin, et al.. Does the progesterone receptor genetic polymorphism +331G/A hPR influence the risk of venous thromboembolism among postmenopausal women using hormone therapy? The ESTHER Study.. Maturitas, Elsevier, 2009, 64 (2), pp.136-8. 〈10.1016/j.maturitas.2009.08.013〉. 〈inserm-01142841〉

Partager

Métriques

Consultations de la notice

145

Téléchargements de fichiers

67